Skip to main content

Table 1 Characteristics and outcomes of participants categorized by SHR

From: The prognostic impact of stress hyperglycemia ratio on mortality in cardiogenic shock: a MIMIC-IV database analysis

SHR

Total

(n = 904)

T1 (< 1.005)

(n = 301)

T2 (1.005–1.395)

(n = 305)

T3 (≥ 1.395)

(n = 298)

p value

Demographic

     

Age, years, mean(SD)

67.62 (13.51)

67.60 (13.73)

67.26 (13.62)

68.02 (13.20)

0.787

Male, n(%)

608 (67.3%)

200 (66.4%)

209 (68.5%)

199 (66.8%)

0.842

Race, White, n(%)

537 (59.4%)

168 (55.8%)

200 (65.6%)

169 (56.7%)

0.026

BMI, Kg/m2, mean(SD)

29.16 (6.79)

29.40 (6.83)

29.38 (7.32)

28.70 (6.18)

0.447

Vital signs

     

SBP, mmHg, mean (SD)

112.9 (21.0)

111.3 (19.9)

113.1 (19.7)

114.4 (23.4)

0.190

DBP, mmHg, mean (SD)

66.3 (18.1)

64.6 (16.7)

65.0 (17.4)

69.4 (19.9)

0.001

Respiratory rate, bpm, mean (SD)

20.3 (6.3)

19.5 (6.0)

20.3 (6.3)

21.2 (6.3)

0.004

HR, bpm, mean (SD)

90.2 (20.6)

86.8 (18.1)

91.0 (21.9)

92.7 (21.1)

0.001

Comorbidities, n(%)

     

Myocardial infarction

396 (43.8%)

99 (32.9%)

128 (42.0%)

169 (56.7%)

< 0.001

Heart failure

736 (81.4%)

253 (84.1%)

245 (80.3%)

238 (79.9%)

0.351

Cerebrovascular disease

154 (17.0%)

52 (17.3%)

55 (18.0%)

47 (15.8%)

0.754

Chronic pulmonary disease

228 (25.2%)

86 (28.6%)

67 (22.0%)

75 (25.2%)

0.173

Liver disease

111 (12.3%)

48 (15.9%)

35 (11.5%)

28 (9.4%)

0.044

Diabetes

380 (42.0%)

145 (48.2%)

108 (35.4%)

127 (42.6%)

0.006

Chronic renal disease

310 (34.3%)

111 (36.9%)

111 (36.4%)

88 (29.5%)

0.106

Malignant cancer

38 (4.2%)

8 (2.7%)

18 (5.9%)

12 (4.0%)

0.136

Laboratory parameters

     

Lactate, mmol/L, median (IQR)

1.80 (1.30, 3.00)

1.55 (1.10, 2.20)

1.70 (1.20, 2.40)

2.60 (1.50, 4.20)

< 0.001

WBC, K/μL, median (IQR)

11.90 (8.70, 16.20)

9.80 (7.25, 13.10)

12.10 (9.05, 16.20)

13.80 (10.50, 19.23)

< 0.001

Platelet, K/μL, median (IQR)

204 (150, 262)

192 (133, 242)

202 (150, 256)

227 (172, 292)

< 0.001

Hemoglobin, g/dL, mean (SD)

11.50 (2.65)

11.23 (2.75)

11.34 (2.43)

11.95 (2.70)

0.001

Neutrophile, K/μL, median (IQR)

10.68 (7.48, 14.60)

8.69 (6.27, 12.14)

10.87 (8.14, 14.57)

12.46 (8.68, 16.08)

< 0.001

Lymphocyte, K/μL, median (IQR)

1.30 (0.82, 2.12)

1.51 (0.85, 2.16)

1.29 (0.81, 2.15)

1.24 (0.79, 2.05)

0.212

BUN, mg/dL, median (IQR)

27.0 (18.0, 44.0)

29.0 (18.5, 45.0)

27.0 (17.0, 42.5)

24.5 (17.0, 43.0)

0.308

Creatinine, mg/dL, median (IQR)

1.30 (1.00, 2.00)

1.30 (1.00, 2.00)

1.30 (1.00, 1.95)

1.40 (1.00, 2.00)

0.583

Calcium, mg/dL, mean (SD)

8.57 (0.97)

8.59 (1.04)

8.59 (0.79)

8.51 (1.08)

0.538

Chloride, mEq/L, mean (SD)

100.91 (6.90)

101.52 (6.61)

100.72 (6.76)

100.49 (7.30)

0.156

Sodium, mEq/L, mean (SD)

136.60 (5.22)

137.41 (4.71)

136.28 (4.94)

136.13 (5.87)

0.004

Potassium, mEq/L, mean (SD)

4.50 (0.95)

4.43 (0.95)

4.42 (0.79)

4.65 (1.08)

0.005

Albumin, g/dL, mean (SD)

3.27 (0.59)

3.24 (0.60)

3.28 (0.56)

3.30 (0.61)

0.458

Total Bilirubin, mg/dL, median (IQR)

0.70 (0.50, 1.20)

0.80 (0.50, 1.40)

0.70 (0.50, 1.25)

0.70 (0.40, 1.10)

0.112

ALT, U/L, median (IQR)

41.0 (20.0, 114.8)

32.0 (18.0, 98.0)

37.0 (19.5, 108.5)

53.5 (23.0, 150.3)

0.003

AST, U/L, median (IQR)

74.0 (32.0, 237.0)

55.0 (27.0, 175.0)

70.0 (32.5, 214.5)

108.0 (40.0, 307.0)

< 0.001

INR, median (IQR)

1.40 (1.20, 1.70)

1.50 (1.20, 1.80)

1.40 (1.20, 1.70)

1.30 (1.10, 1.60)

< 0.001

PT, median (IQR)

14.8 (12.8, 18.5)

16.0 (13.3, 19.6)

14.9 (12.8, 18.1)

13.7 (12.4, 17.2)

< 0.001

PTT, median (IQR)

34.8 (28.8, 57.0)

34.5 (29.5, 51.1)

34.3 (28.6, 51.5)

36.6 (28.3, 70.2)

0.250

Glucose, mg/dL, mean (SD)

179.87 (100.10)

117.44 (38.70)

156.43 (50.16)

266.92 (119.41)

< 0.001

HbA1c, %, mean (SD)

6.49 (1.67)

6.97 (2.01)

6.24 (1.39)

6.27 (1.46)

< 0.001

SHR, mean (SD)

1.326 (0.636)

0.796 (0.166)

1.182 (0.114)

2.009 (0.644)

< 0.001

Sofa score, median (IQR)

2.0 (0.0, 4.0)

2.0 (0.5, 4.0)

2.0 (0.0, 4.0)

2.0 (0.0, 4.0)

0.975

Sapsii score, median (IQR)

40.0 (31.3, 50.0)

38.0 (30.0, 48.0)

39.0 (31.0, 49.0)

43.0 (34.8, 54.0)

< 0.001

Lods score, median (IQR)

6.0 (4.0, 8.0)

6.0 (4.0, 8.0)

6.0 (4.0, 8.0)

7.0 (5.0, 9.0)

0.002

Oasis score, median (IQR)

33.0 (27.0, 40.0)

31.0 (26.0, 38.0)

33.0 (27.0, 39.0)

36.0 (30.0, 41.0)

< 0.001

Sirs score, median (IQR)

3.0 (2.0, 3.0)

3.0 (2.0, 3.0)

3.0 (2.0, 3.0)

3.0 (3.0, 3.0)

< 0.001

Charlson score, median (IQR)

6.0 (4.0, 8.0)

6.0 (4.0, 8.0)

6.0 (4.0, 8.0)

6.0 (4.0, 8.0)

0.562

  1. SHR: stress hyperglycemia ratio; SD: standard deviation; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; ALT: alanine aminotransferase; AST: aspartate aminotransferase; INR: international normalized ratio; PT: prothrombin time; PTT: partial tromboplastin time